Trial Outcomes & Findings for The Effects of White Noise for Adult Patients' Sleep Quality in Intensive Care Unit. (NCT NCT05785130)

NCT ID: NCT05785130

Last Updated: 2025-03-17

Results Overview

Sleep quality is assessed using the Verran and Snyder-Halpern (VSH) Sleep Scale, a subjective sleep scale that contains three dimensions: sleep disturbance, sleep effectiveness, and sleep supplementation, with a total of 15 items. Scores are measured using a visual analogue scale, which is a 100mm horizontal line. The maximum score is 100, and the minimum score is 0. The total score of the VSH Sleep Scale (VSHSS) ranges from 0 to 1500. The subscales are combined by summing the individual scores for each item, and the total score is obtained by adding the scores from each of the subscales. The lower the score, the poorer the sleep quality. Outcomes were measured at baseline, the first intervention day (T1), the third intervention day (T2), and two days after the intervention (T3) for both groups.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

60 participants

Primary outcome timeframe

Baseline, 1st days, 3rd days and 5th days.

Results posted on

2025-03-17

Participant Flow

Participants were recruited at in a medical center at southern Taiwan from March 2023 to August 2024.

Of 60 enrolled participants, 60 meets inclusion criteria and were randomized to white noise or conventional treatment group

Participant milestones

Participant milestones
Measure
White Noise Group
white noise at bedtime. white noise: Using sound machine for 3 days at bedtime for 7 hours(11p.m.- 6a.m.) in a decibel of 40-50.
Conventional Treatment Group
Treatment as usual without white noise intervention
Overall Study
STARTED
30
30
Overall Study
COMPLETED
29
29
Overall Study
NOT COMPLETED
1
1

Reasons for withdrawal

Reasons for withdrawal
Measure
White Noise Group
white noise at bedtime. white noise: Using sound machine for 3 days at bedtime for 7 hours(11p.m.- 6a.m.) in a decibel of 40-50.
Conventional Treatment Group
Treatment as usual without white noise intervention
Overall Study
Withdrawal by Subject
1
0
Overall Study
Lack of Efficacy
0
1

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
White Noise Group
n=29 Participants
white noise at bedtime. white noise: Using sound machine for 3 days at bedtime for 7 hours(11p.m.- 6a.m.) in a decibel of 40-50.
Conventional Treatment Group
n=29 Participants
Treatment as usual. without white nose intervention.
Total
n=58 Participants
Total of all reporting groups
Age, Continuous
63.76 years
STANDARD_DEVIATION 11.07 • n=29 Participants
59.69 years
STANDARD_DEVIATION 15.74 • n=29 Participants
61.72 years
STANDARD_DEVIATION 13.24 • n=58 Participants
Sex: Female, Male
Female
15 Participants
n=29 Participants
10 Participants
n=29 Participants
25 Participants
n=58 Participants
Sex: Female, Male
Male
14 Participants
n=29 Participants
19 Participants
n=29 Participants
33 Participants
n=58 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
APACHE II
20.41 units on a scale
STANDARD_DEVIATION 4.05 • n=29 Participants
21.48 units on a scale
STANDARD_DEVIATION 5.77 • n=29 Participants
20.95 units on a scale
STANDARD_DEVIATION 4.97 • n=58 Participants
comorbidity
1.66 number of comorbidities
STANDARD_DEVIATION 0.94 • n=29 Participants
1.59 number of comorbidities
STANDARD_DEVIATION 1.30 • n=29 Participants
1.62 number of comorbidities
STANDARD_DEVIATION 1.12 • n=58 Participants
Critical Care Pain Observation Tool(CPOT)
0.45 scores on a scale
STANDARD_DEVIATION 0.87 • n=29 Participants
0.83 scores on a scale
STANDARD_DEVIATION 1.20 • n=29 Participants
0.64 scores on a scale
STANDARD_DEVIATION 1.05 • n=58 Participants
Education years
10.62 years
STANDARD_DEVIATION 3.24 • n=29 Participants
10.72 years
STANDARD_DEVIATION 3.28 • n=29 Participants
10.67 years
STANDARD_DEVIATION 3.24 • n=58 Participants
Use painkiller
Yes
9 Participants
n=29 Participants
12 Participants
n=29 Participants
21 Participants
n=58 Participants
Use painkiller
No
20 Participants
n=29 Participants
17 Participants
n=29 Participants
37 Participants
n=58 Participants
Use hypnotic
Yes
3 Participants
n=29 Participants
1 Participants
n=29 Participants
4 Participants
n=58 Participants
Use hypnotic
No
26 Participants
n=29 Participants
28 Participants
n=29 Participants
54 Participants
n=58 Participants

PRIMARY outcome

Timeframe: Baseline, 1st days, 3rd days and 5th days.

Sleep quality is assessed using the Verran and Snyder-Halpern (VSH) Sleep Scale, a subjective sleep scale that contains three dimensions: sleep disturbance, sleep effectiveness, and sleep supplementation, with a total of 15 items. Scores are measured using a visual analogue scale, which is a 100mm horizontal line. The maximum score is 100, and the minimum score is 0. The total score of the VSH Sleep Scale (VSHSS) ranges from 0 to 1500. The subscales are combined by summing the individual scores for each item, and the total score is obtained by adding the scores from each of the subscales. The lower the score, the poorer the sleep quality. Outcomes were measured at baseline, the first intervention day (T1), the third intervention day (T2), and two days after the intervention (T3) for both groups.

Outcome measures

Outcome measures
Measure
White Noise Group
n=29 Participants
Background noise at bedtime. white noise: Using sound machine for 3 days at bedtime for 7 hours(11p.m.- 6a.m.) in a decibel of 40-50.
Conventional Treatment Group
n=29 Participants
Treatment as usual without white noise intervention.
The Verran and Snyder-Halpern Sleep Scale Scores on Baseline, the First Intervention Day(T1), the Third Intervention Day(T2), and Follow up Two Days Later After Intervention (T3) Between Two Groups.
baseline(T0)
873.38 score on a scale
Standard Deviation 262.24
898.45 score on a scale
Standard Deviation 312.80
The Verran and Snyder-Halpern Sleep Scale Scores on Baseline, the First Intervention Day(T1), the Third Intervention Day(T2), and Follow up Two Days Later After Intervention (T3) Between Two Groups.
the first intervention day(T1)
880.48 score on a scale
Standard Deviation 226.89
746.91 score on a scale
Standard Deviation 323.38
The Verran and Snyder-Halpern Sleep Scale Scores on Baseline, the First Intervention Day(T1), the Third Intervention Day(T2), and Follow up Two Days Later After Intervention (T3) Between Two Groups.
the third intervention day (T2)
901.84 score on a scale
Standard Deviation 259.23
665.91 score on a scale
Standard Deviation 300.58
The Verran and Snyder-Halpern Sleep Scale Scores on Baseline, the First Intervention Day(T1), the Third Intervention Day(T2), and Follow up Two Days Later After Intervention (T3) Between Two Groups.
two days after the intervention (T3)
774.17 score on a scale
Standard Deviation 277.87
559.99 score on a scale
Standard Deviation 268.25

Adverse Events

White Noise Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Conventional Treatment Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Ya-Ching, Nien

ChangGung Memorial Hospital

Phone: +886 913112012

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place